The fine folks at FierceBiotech released their anticipated “Fierce 15” list today – the companies that they feel have an excellent chance at “producing something revolutionary and game-changing” in the next 5 to 10 years, “a genuine chance of being the Next Big Thing.”
The majority of the companies in the list raised early capital of at least $50 million. FierceBiotech notes that “it’s the promise of the science and the teams managing these candidates, alongside a genuine excitement and confidence in new hopes for truly next-generation therapies” that is driving the capital.
FierceBiotech notes further that “many veterans” from Big Pharma “have jumped ship to these startups—including ex-Biogen chief George Scangos, former Novartis leader David Epstein, former Allergan oncology VP Stephen Eck, Clovis Andrew cofounder Andrew Allen, ex-GlaxoSmithKline exec Jason Gardner, Genentech vet Raphaël Rousseau and former Pfizer leader Torben Straight Nissen.”
We encourage you to visit FierceBiotech and review the detailed profiles of the Fierce 15.
Source: Data from FierceBiotech. Chart by Equities.com
Please email us at [email protected] to see our Case Studies and Testimonials.
Please click here for information on our new trading platform.
Please click here to subscribe to our complimentary newsletter.
Trending Now
1
2
Read Next
Thought Leaders
Introducing the NEW Equities News: Transforming the world by investing in what matters most
Paula DeLaurentis
Mar 15, 2024
Economic
An opportunity for women in the clean-energy transition
Green Money
Mar 12, 2024
Economic
Making diversity in venture-capital funding a priority
Yinka Faleti
Mar 11, 2024
Environment
E-bike incentives are a costly way to cut carbon emissions, but they also promote health
The Conversation
Mar 7, 2024
3 dividend-paying health-care stocks that top analysts recommend
Benzinga
Mar 7, 2024
Economic
The true cost of food is far higher than what you spend at the grocery checkout
The Conversation
Mar 6, 2024
The Latest
Thought Leaders
Introducing the NEW Equities News: Transforming the world by investing in what matters most
Mar 15, 2024
Economic
An opportunity for women in the clean-energy transition
Mar 12, 2024
Economic
Making diversity in venture-capital funding a priority
Mar 11, 2024
Environment
E-bike incentives are a costly way to cut carbon emissions, but they also promote health
Mar 7, 2024